Home > National Drug Code (NDC) > Terazosin Hydrochloride Anhydrous

Terazosin Hydrochloride Anhydrous - 0378-2268-10 - (terazosin hydrochloride anhydrous)

Alphabetical Index


Drug Information of Terazosin Hydrochloride Anhydrous

Product NDC: 0378-2268
Proprietary Name: Terazosin Hydrochloride Anhydrous
Non Proprietary Name: terazosin hydrochloride anhydrous
Active Ingredient(s): 5    mg/1 & nbsp;   terazosin hydrochloride anhydrous
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Terazosin Hydrochloride Anhydrous

Product NDC: 0378-2268
Labeler Name: Mylan Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075140
Marketing Category: ANDA
Start Marketing Date: 20130222

Package Information of Terazosin Hydrochloride Anhydrous

Package NDC: 0378-2268-10
Package Description: 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-2268-10)

NDC Information of Terazosin Hydrochloride Anhydrous

NDC Code 0378-2268-10
Proprietary Name Terazosin Hydrochloride Anhydrous
Package Description 1000 CAPSULE in 1 BOTTLE, PLASTIC (0378-2268-10)
Product NDC 0378-2268
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name terazosin hydrochloride anhydrous
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20130222
Marketing Category Name ANDA
Labeler Name Mylan Pharmaceuticals Inc.
Substance Name TERAZOSIN HYDROCHLORIDE ANHYDROUS
Strength Number 5
Strength Unit mg/1
Pharmaceutical Classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of Terazosin Hydrochloride Anhydrous


General Information